Status:
UNKNOWN
Olive Leaf Extracts in the Control of Cardiovascular Risk
Lead Sponsor:
University of Monastir
Conditions:
Diabetes Mellitus, Type 2
Hypertension
Eligibility:
All Genders
18-100 years
Phase:
PHASE2
PHASE3
Brief Summary
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal ho...
Detailed Description
This study will be carried out in 2 emergency departments (at the exit of the emergency room, patients included in the GR2 study) and 2 external consultations (endocrinology of the CHU FB Monastir and...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients over 18 years of age with:
- Arterial hypertension (hypertension).
- Or diabetes.
- Or one or more other cardiovascular risk factors (AHA, ESC) or risk of cardiovascular disease\> 20% according to the Framingham scale (apart from hypertension and diabetes.
- Criteria exclusion:
- . Exclusion criteria: None.
Exclusion
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05297110
Start Date
August 1 2021
End Date
December 1 2023
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fattouma Bourguiba Monastir University Hospital Center
Monastir, Tunisia, 5000